Healthcare provider profile · identity verified

Robert M Rose, M.D.

Family Practice · KING WILLIAM, VA · NPI 1730527342

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	578	166
Amlodipine Besylate	Amlodipine Besylate	540	166
Hydrochlorothiazide	Hydrochlorothiazide	465	139
Pravastatin Sodium	Pravastatin Sodium	457	143
Lisinopril	Lisinopril	439	129
Losartan Potassium	Losartan Potassium	338	105
Omeprazole	Omeprazole	328	95
Metformin Hcl	Metformin Hcl	294	83
Pantoprazole Sodium	Pantoprazole Sodium	270	92
Levothyroxine Sodium	Levothyroxine Sodium	251	73
Metformin Hcl Er	Metformin Hcl	212	70
Simvastatin	Simvastatin	208	61
Metoprolol Succinate	Metoprolol Succinate	204	64
Gabapentin	Gabapentin	202	70
Rosuvastatin Calcium	Rosuvastatin Calcium	201	60
Tamsulosin Hcl	Tamsulosin Hcl	186	55
Furosemide	Furosemide	177	54
Trazodone Hcl	Trazodone Hcl	170	50
Metoprolol Tartrate	Metoprolol Tartrate	168	42
Duloxetine Hcl	Duloxetine Hcl	164	45
Albuterol Sulfate Hfa	Albuterol Sulfate	152	54
Allopurinol	Allopurinol	146	45
Glipizide	Glipizide	135	46
Tizanidine Hcl	Tizanidine Hcl	133	50
Sertraline Hcl	Sertraline Hcl	124	37
Montelukast Sodium	Montelukast Sodium	108	35
Alendronate Sodium	Alendronate Sodium	106	34
Spironolactone	Spironolactone	98	29
Fluoxetine Hcl	Fluoxetine Hcl	90	26
Diclofenac Sodium	Diclofenac Sodium	85	27
Potassium Chloride	Potassium Chloride	79	23
Eliquis	Apixaban	77	21
Nortriptyline Hcl	Nortriptyline Hcl	77	30
Atenolol	Atenolol	75	20
Jardiance	Empagliflozin	70	20
Clopidogrel	Clopidogrel Bisulfate	68	20
Famotidine	Famotidine	64	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	64	17
Valsartan	Valsartan	64	15
Carvedilol	Carvedilol	62	18
Escitalopram Oxalate	Escitalopram Oxalate	62	19
Finasteride	Finasteride	58	20
Lorazepam	Lorazepam	58	16
Fluticasone Propionate	Fluticasone Propionate	56	20
Warfarin Sodium	Warfarin Sodium	56	15
Doxycycline Hyclate	Doxycycline Hyclate	55	44
Zolpidem Tartrate	Zolpidem Tartrate	55	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	19
Paroxetine Hcl	Paroxetine Hcl	53	15
Synthroid	Levothyroxine Sodium	53	14
Lovastatin	Lovastatin	52	16
Ezetimibe	Ezetimibe	50	16
Baclofen	Baclofen	46	suppressed
Prednisone	Prednisone	46	33
Meloxicam	Meloxicam	43	12
Alprazolam	Alprazolam	42	17
Buspirone Hcl	Buspirone Hcl	41	suppressed
Ozempic	Semaglutide	41	13
Trulicity	Dulaglutide	41	12
Azithromycin	Azithromycin	40	38
Citalopram Hbr	Citalopram Hydrobromide	39	12
Clonidine Hcl	Clonidine Hcl	39	13
Clonazepam	Clonazepam	38	suppressed
Donepezil Hcl	Donepezil Hcl	36	13
Sucralfate	Sucralfate	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	20
Amitriptyline Hcl	Amitriptyline Hcl	35	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	35	suppressed
Celecoxib	Celecoxib	33	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	32	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	31	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	31	18
Bumetanide	Bumetanide	30	suppressed
Glipizide Er	Glipizide	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	13
Mounjaro	Tirzepatide	29	suppressed
Enalapril Maleate	Enalapril Maleate	28	suppressed
Methocarbamol	Methocarbamol	28	suppressed
Primidone	Primidone	28	suppressed
Benazepril Hcl	Benazepril Hcl	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Phenobarbital	Phenobarbital	27	suppressed
Ondansetron Odt	Ondansetron	26	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	26	suppressed
Indapamide	Indapamide	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Divalproex Sodium	Divalproex Sodium	24	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Colchicine	Colchicine	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Pregabalin	Pregabalin	23	12
Xarelto	Rivaroxaban	23	suppressed
Diazepam	Diazepam	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Nebivolol Hcl	Nebivolol Hcl	22	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Naproxen	Naproxen	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Doxepin Hcl	Doxepin Hcl	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Breyna	Budesonide/Formoterol Fumarate	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	14
Gemfibrozil	Gemfibrozil	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	12
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Repatha Sureclick	Evolocumab	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	12
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Desmopressin Acetate	Desmopressin Acetate	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Glyburide	Glyburide	12	suppressed
Imipramine Hcl	Imipramine Hcl	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Mycophenolic Acid	Mycophenolate Sodium	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Risperdal Consta	Risperidone Microspheres	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error